Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New test developed to diagnose Brucella canis
The new test is able to measure antibody levels.
The CBM assay is already being used in the USA.

Researchers have developed a new diagnostic test for Brucella canis that is able to measure the number of antibodies in infected dogs.

In contrast to previous tests, which could only detect whether or not antibodies were present, the new Canine Brucella Multiplex (CBM) assay makes it possible to monitor how an infected dog is responding to treatment.

However, a reduction in the number of antibodies does not necessarily mean that the infection is no longer present, as it can be sequestered in tissue.

Created by researchers at the Cornell University College of Veterinary Medicine (CVM), the test is already being used to diagnose dogs in the USA, where up to six per cent of dogs are affected by the disease.

Dr Toby Pinn-Woodcock, an assistant clinical professor at CVM, said: “We’re testing hundreds of dogs per month. We believe that this test is more sensitive and less prone to false-positive results.”

Although Brucella canis is not currently endemic in the UK, there has been a spike in cases of the zoonotic disease since 2020, with cases found in dogs imported from Europe and elsewhere. In 2022, 54 cases were reported, along with the first recorded case of dog-to-human transmission in the UK.

In February, the BSAVA published a Scientific Information Document to provide veterinary professionals with information about the disease. Currently, euthanasia of infected dogs is considered the only way to prevent any risk of transmission, although there are steps that can be taken to try to reduce the risk of transmission when owners choose not to euthanise.

Following the development of the new test, the researchers at CVM are seeking funding to study whether a prolonged decrease in the amount of antibodies could be a sign that a dog is cured of the disease.

Cassandra Guarino, assistant professor at CVM, said: “In theory, if the [antibody] values come down and stay down for a certain amount of time, we may be able to say with confidence that the animal has successfully cleared the infection, but we’re not quite there yet.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.